Human parainfluenza virus 4 (HPIV‑4) is an enveloped, single‑stranded, negative‑sense RNA virus in the genus Rubulavirus of the family Paramyxoviridae. It is one of the four antigenically distinct human parainfluenza viruses but is detected less frequently than types 1‑3 and typically causes milder disease.
Virology & Pathogenesis
HPIV‑4 has a nonsegmented negative‑sense RNA genome of roughly 15 kilobases encoding six structural proteins (N, P, M, F, HN and L). As a rubulavirus it also expresses accessory proteins such as V and C that modulate the host interferon response. The hemagglutinin–neuraminidase (HN) glycoprotein binds sialic‑acid–containing receptors on respiratory epithelial cells and possesses neuraminidase activity that aids virus release; the fusion (F) protein mediates fusion of the viral envelope with the host cell membrane. After entry, the virion-associated polymerase transcribes the genome and replicates it according to the “rule of six.” Two antigenic subtypes, HPIV‑4A and HPIV‑4B, have been described. HPIV‑4 is classified in the genus Rubulavirus together with HPIV‑2. Replication appears to be largely confined to the upper respiratory epithelium, and the virus generally induces less cytopathology than HPIV‑1 or HPIV‑3.
Clinical characteristics
HPIV‑4 circulates sporadically and is less well characterised than other parainfluenza viruses. It is usually associated with mild upper respiratory tract infections presenting with cough, rhinorrhea, sore throat and low‑grade fever. Outbreaks are uncommon and are often detected incidentally when respiratory panels are performed. HPIV‑4 rarely causes croup; most cases of croup are due to HPIV‑1, HPIV‑2 and HPIV‑3. Infections can occur in both children and adults, and severe lower respiratory disease is uncommon but has been reported in immunocompromised patients and infants. There is no licensed vaccine or specific antiviral therapy; management is supportive and includes rest, hydration and symptom relief. Standard infection control measures such as hand hygiene and isolation of symptomatic individuals help prevent spread. Although HPIV‑4 is less prevalent than the other human parainfluenza viruses, it contributes to the spectrum of respiratory illness and underscores the diversity within the Paramyxoviridae family. Related Terms: Paramyxoviridae, Rubulavirus, Upper respiratory infection, Hemagglutinin–neuraminidase, Fusion protein